TRIM25 and neoplasm: In the present study, we revealed that TRIM25 was a significant predictor of poor prognosis in patients with CRC treated with OXA, and high expression of TRIM25 predicted tumor recurrence, suggesting that TRIM25 is involved in OXA resistance.